Robert James Wills
Chair, Oncternal Therapeutics, Inc.
Companies
- Alpha Cognition Inc.Board member Apr 9, 2025 to now1
- Milestone Pharmaceuticals Inc.Board member Oct 5, 2020 to now2
- Oncternal Therapeutics, Inc.Board member Sep 16, 2019 to Jun 24, 20243
- CymaBay Therapeutics (United States)Board member Apr 6, 2015 to Mar 22, 20244
- Oncternal Therapeutics, Inc.Chair Mar 4, 2015 to Jun 26, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Alpha Cognition Inc. ACOG32,241 shares6$271.6K at $8.43Aug 21, 2026
- Milestone Pharmaceuticals Inc. MIST65,000 shares7$46.0K at $0.71Jul 11, 2025
- CymaBay Therapeutics (United States)0 shares8Mar 22, 2024
- Oncternal Therapeutics, Inc.10,000 shares9Apr 8, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 21, 2026Bought 10,000 shares at $9.62 of Alpha Cognition Inc.6
- Jan 14, 2026Granted 7,241 shares of Alpha Cognition Inc.10
- Aug 18, 2025Bought 15,000 shares at $8.49 of Alpha Cognition Inc.11
- Jul 11, 2025Granted 50,000 shares of Milestone Pharmaceuticals Inc.7
- Apr 8, 2024Bought 3,086 shares at $8.96 of Oncternal Therapeutics, Inc.9
- Mar 28, 2024Bought 6,914 shares at $8.48 of Oncternal Therapeutics, Inc.12
- Mar 22, 2024Returned to company 30,000 shares of CymaBay Therapeutics (United States)8
- Feb 23, 2024Sold 980 shares at $9.04 of Oncternal Therapeutics, Inc.13
- Oct 19, 2022Bought 15,000 shares at $4.93 of Milestone Pharmaceuticals Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAlpha Cognition Inc., Board member
- 2
- 3
- 4
- 5SEC EDGAROncternal Therapeutics, Inc., Chair
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jan 16, 2026
- 11SEC EDGARForm 4 filed Aug 21, 2025
- 12SEC EDGARForm 4 filed Apr 1, 2024
- 13SEC EDGARForm 4 filed Feb 27, 2024
- 14SEC EDGARForm 4 filed Oct 21, 2022